Active Biotech AB publ banner
A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.0667 SEK 9.34%
Market Cap: kr116.7m

Active Biotech AB publ
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Active Biotech AB publ
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
A
Active Biotech AB publ
STO:ACTI
Intangible Assets
kr245k
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Intangible Assets
kr702k
CAGR 3-Years
-75%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Intangible Assets
kr14.9m
CAGR 3-Years
21%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Intangible Assets
kr3.8B
CAGR 3-Years
-6%
CAGR 5-Years
67%
CAGR 10-Years
37%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Intangible Assets
kr40.1B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
25%
BioArctic AB
STO:BIOA B
Intangible Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Active Biotech AB publ
Glance View

Market Cap
116.7m SEK
Industry
Biotechnology

Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

ACTI Intrinsic Value
0.0436 SEK
Overvaluation 35%
Intrinsic Value
Price kr0.0667
A

See Also

What is Active Biotech AB publ's Intangible Assets?
Intangible Assets
245k SEK

Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Intangible Assets amounts to 245k SEK.

What is Active Biotech AB publ's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
0%

Over the last year, the Intangible Assets growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett